2-Phenoxy-1-piperazin-1-yl-ethanone xhydrochloride, 95.0%, 1g

Methyl4-chloro-2-oxo-1,3-dihydropyrrolo[2,3-b]pyridine-5-carboxylate, 98%, 500mg

6-Bromo-1-(trifluoromethyl)isoquinoline, 97%, 250mg

Calcéine, pa, 25 g, emballage en verre

(S)-2-(2-CHLOROPHENYL)-2-((2-(THIOPHEN-2-YL)ETHYL)AMINO)ACETIC ACID, 95%, 250mg

(4R,4'R)-1,1'-Bis(3-(tert-butyl)phenyl)-4,4'-dicyclohexyl-4,4',5,5'-tetrahydro-1H,1'H-2,2'-biimidazole, 98%, 250mg

Ethyl 2,3-dichlorobenzoate, 95.0%, 25g

(1-Methyl-4-oxo-1,4-dihydro-pyrazolo[3,4-d]pyrimidin-5-yl)-acetic acid, 100mg

(Bromoethynyl)triisopropylsilane, 97%, 50g

Methyl 4-(2-((2,4-diaminopteridin-6-yl)methyl)-1-methoxy-1-oxopent-4-yn-2-yl)benzoate hydrobromide, 98%, 5g

5-Methyl-3-[4-(trifluoromethyl)phenyl]-1,2,4-oxadiazole, 1g

Noir brillant BN (CI 28440), pa, 5 g, emballage verre

2,3-Dichloropyridine-4-boronic acid, 95.0%, 5g